Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function

Recruiting now · Not applicable

Conditions studied: Benign Ovarian Cyst

In brief

This study aims to evaluate the efficacy of preservation of ovarian function, hemostasis, and safety of a hemostatic agent versus suturing during laparoscopic ovarian cystectomy for ovarian endometriosis.

Key facts

Study ID

NCT04643106

Run by

Seoul National University Hospital

People needed

90

Starts

2021-02-25

Expected to finish

2026-12-31

Last updated by the study team

2023-06-26

Who can join

Age: 19 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Informed consent.
• Age: 19-45 year-old women
• American Society of Anesthesiologists Physical Status classification 1 or 2
• Plan of laparoscopic ovarian cystectomy for unilateral or bilateral ovarian endometriosis diagnosed by ultrasonography
• Regular menstruation every 21-45 days

You may not qualify if…

• No 'ovarian' endometriosis
• Suspicious disease of ovarian malignancy
• Age: 18 and younger, 46 and older
• Pregnancy or breastfeeding.
• Lower than 0.05 ng/ml of serum Anti-mullerian hormone level
• Hormonal therapy within recent 3 months
• Considered as inappropriate by the researcher's judgment.

Where it is running

• Seoul National University Hospital — Seoul, South Korea (enrolling)
• Dongguk University Ilsan Hospital — Goyang-si, Gyeonggi-do, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.